Trial intelligence / Profile preview

Antibiotic Pretreatment for WMT in Chronic Constipation

NCT06427863Not yet recruiting

Start
Jun 2024
Primary completion
Dec 2029
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in chronic constipation comparing Ornidazole + WMT with Placebo + WMT (2 arms). Primary endpoints: Response rate of complete spontaneous bowel movements at 8 weeks, Change in Constipation Assessment Scale at 8 weeks and 1 more. Planned start Jun 2024; status: not yet recruiting.

02

Drugs

ornidazole
03

Conditions

chronic constipation

Beyond the preview

Go deeper on NCT06427863.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06427863.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call